Abstract
Get full access to this article
View all access options for this article.
References
1.
Nossent H.S.
,
Swaak T.J.G.
,
Berden J.H.M.
Systemic lupus erythematosus: Analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Am J Med 1990 ; 89 : 169 –74 .
2.
Rodby R.A.
,
Korbet S.M.
,
Lewis E.J.
Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis. Am J Med 1987 ; 83 : 613 –18 .
3.
Mojcik C.F.
,
Kippel J.H.
End-stage renal disease and systemic lupus erythematosus. Am J Med 1996 ; 101 : 100 –7 .
4.
Wu G.G.
,
Gelbart D.R.
,
Hasbargen J.A.
,
Inman R.
,
McNamee P.
,
Oreopoulos D.G.
Reactivation of systemic lupus in three patients undergoing CAPD. Perit Dial Bull 1986 ; 6 : 6 –9 .
5.
Huang J-W
,
Hung K-Y
,
Yen C-J
,
Wu K-D
,
Tsai T-J
. Systemic lupus erythematosus and peritoneal dialysis: Outcomes and infectious complications. Perit Dial Int 2001 ; 21 : 143 –7 .
6.
Dziadzio M.
,
Denton C.P.
,
Smith R.
,
Howell K.
,
Blann A.
,
Bowers E.
Losartan therapy for Raynaud's phenomenon and scleroderma. Arthritis Rheum 1999 ; 42 : 1646 –55 .